The role of adenoviral vectors in genetic prodrug activation therapy in prostate cancer

J D Eaton, I A Clarke, H Pandha, A G Dalgleish, R S Kirby

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S10
Journal	Prostate Cancer and Prostatic Diseases
Volume	3
Issue number	S1
DOIs	https://doi.org/10.1038/sj.pcan.4500449
Publication status	Published - 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{018fcd8f66db4bc49e1cc4443e67e904,

title = "The role of adenoviral vectors in genetic prodrug activation therapy in prostate cancer",

author = "Eaton, {J D} and Clarke, {I A} and H Pandha and Dalgleish, {A G} and Kirby, {R S}",

year = "2000",

doi = "10.1038/sj.pcan.4500449",

language = "English",

volume = "3",

pages = "S10",

journal = "Prostate Cancer and Prostatic Diseases",

issn = "1365-7852",

publisher = "Nature Publishing Group",

number = "S1",

}

TY - JOUR

T1 - The role of adenoviral vectors in genetic prodrug activation therapy in prostate cancer

AU - Eaton, J D

AU - Clarke, I A

AU - Pandha, H

AU - Dalgleish, A G

AU - Kirby, R S

PY - 2000

Y1 - 2000

U2 - 10.1038/sj.pcan.4500449

DO - 10.1038/sj.pcan.4500449

M3 - Article

C2 - 12497120

VL - 3

SP - S10

JO - Prostate Cancer and Prostatic Diseases

JF - Prostate Cancer and Prostatic Diseases

SN - 1365-7852

IS - S1

ER -